Fierce competition within relapsing remitting MS (RRMS) has been beneficial in bringing pharma into the modern world. From GilenyaGO, to Novartis’ Living Live YOU content hub, to now this lightly branded community from Biogen, Reimagine Myself.
-
- Homepage
-
- Stories section
-
- Video story detail page
-
- Homepage (mobile)
-
- TECFIDERA call-out on mobile